| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Tejara Capital Ltd | 5.2% | $5,323,528 | 5,130,122 | Tejara Capital Ltd | 17 Oct 2025 |
As of 30 Sep 2025, 47 institutional investors reported holding 7,282,619 shares of Cardiol Therapeutics Inc. - Class A Common Shares (CRDL). This represents 7.4% of the company’s total 98,656,192 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 22,052 | $27,407 | +$387 | $1.21 | 3 |
| 2025 Q3 | 7,282,619 | $7,797,682 | +$687,878 | $1.07 | 47 |
| 2025 Q2 | 6,465,422 | $8,796,830 | -$1,669,184 | $1.36 | 38 |
| 2025 Q1 | 7,719,601 | $7,435,013 | +$182,305 | $0.97 | 38 |
| 2024 Q4 | 7,493,301 | $9,599,808 | +$3,011,551 | $1.28 | 43 |
| 2024 Q3 | 4,972,709 | $9,852,940 | -$780,395 | $1.98 | 41 |
| 2024 Q2 | 5,391,195 | $10,832,854 | -$2,207,214 | $2.02 | 41 |
| 2024 Q1 | 6,466,600 | $11,532,275 | +$17,221 | $1.81 | 32 |
| 2023 Q4 | 6,828,316 | $5,921,144 | +$428,207 | $0.84 | 29 |
| 2023 Q3 | 6,315,038 | $5,705,102 | -$336,357 | $0.90 | 31 |
| 2023 Q2 | 6,680,430 | $5,957,333 | -$451,394 | $0.89 | 30 |
| 2023 Q1 | 7,243,437 | $3,537,761 | +$172,240 | $0.49 | 31 |
| 2022 Q4 | 5,656,495 | $2,897,996 | +$187,861 | $0.51 | 28 |
| 2022 Q3 | 4,751,290 | $4,889,869 | -$537,769 | $1.03 | 22 |
| 2022 Q2 | 5,288,416 | $6,964,240 | -$155,145 | $1.32 | 24 |
| 2022 Q1 | 5,387,006 | $8,272,481 | -$917,566 | $1.54 | 26 |
| 2021 Q4 | 5,796,080 | $10,710,997 | +$7,739,960 | $1.85 | 27 |
| 2021 Q3 | 1,605,991 | $6,624,465 | +$6,624,465 | $4.13 | 19 |
| 2021 Q1 | 0 | $0 | -$970,000 | $1.21 | 0 |
| 2020 Q4 | 348,769 | $970,000 | +$171,498 | $2.78 | 1 |
| 2020 Q3 | 287,106 | $876,000 | +$133,036 | $3.05 | 1 |
| 2020 Q2 | 243,504 | $577,000 | +$78,276 | $2.37 | 1 |
| 2020 Q1 | 210,470 | $600,000 | +$50,715 | $2.85 | 1 |
| 2019 Q4 | 192,680 | $681,000 | $3.53 | 1 |